Ardelyx is a publicly traded commercial biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA (tenapanor) and XPHOZAH (tenapanor). Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been approved in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada. Position Summary: We are seeking an Associate Director of Nonclinical Development to join our experienced R&D team supporting drug development programs. The Associate Director will design and implement nonclinical strategies to evaluate and advance Ardelyx's drug candidates through different stages of development. This position involves designing and managing GLP safety studies at contract research organizations (CROs) for early and late-stage programs, analyzing and interpreting safety data, and collaborating with cross-functional teams.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Industry
Chemical Manufacturing
Education Level
Ph.D. or professional degree
Number of Employees
251-500 employees